Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (81-90 of 752) with videos related to

Pageof 76
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelMiklos Rohla, Thomas W Weiss, Johann Wojta, et al.
Cardiology|November 23, 2006
Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and designUwe Zeymer, Hans-Richard Arntz, Harald Darius, et al.
International Journal of Cardiology|August 31, 2016
Copeptin for the early rule-out of non-ST-elevation myocardial infarctionKris G Vargas, Mona Kassem, Christian Mueller, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 2022
Protease-activated receptor-mediated platelet aggregation in patients with type 2 diabetes on potent P2Y<sub>12</sub> inhibitorsBenjamin Panzer, Patricia P Wadowski, Kurt Huber, et al.
International Journal of Cardiology|April 10, 2012
Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular eventsChristoph H Saely, Philipp Rein, Alexander Vonbank, et al.
European Heart Journal. Acute Cardiovascular Care|May 26, 2026
Proteomics profiling for cardiovascular risk prediction: transforming clinical careIsabella Kardys, Manuel Mayr, Johannes Mair, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 17, 2015
Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly menTijana Andric, Thomas W Weiss, Kurt Huber, et al.
Intensive Care Medicine|June 27, 2003
Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shockAlexander Geppert, Angela Steiner, Georg Delle-Karth, et al.
International Journal of Clinical Pharmacy|November 8, 2022
Pharmacist interventions to improve blood pressure control in primary care: a cluster randomised trialMiklos Rohla, Heinz Haberfeld, Maximilian Tscharre, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 updateThomas Cuisset, Marco Valgimigli, Harald Mudra, et al.
Pageof 76

Showing results (81-90 of 752) with videos related to

Sort By:
Pageof 76
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelMiklos Rohla, Thomas W Weiss, Johann Wojta, et al.
Cardiology|November 23, 2006
Efficacy and safety of clopidogrel 600 mg administered pre-hospitally to improve primary percutaneous coronary intervention in patients with acute myocardial infarction (CIPAMI): study rationale and designUwe Zeymer, Hans-Richard Arntz, Harald Darius, et al.
International Journal of Cardiology|August 31, 2016
Copeptin for the early rule-out of non-ST-elevation myocardial infarctionKris G Vargas, Mona Kassem, Christian Mueller, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 6, 2022
Protease-activated receptor-mediated platelet aggregation in patients with type 2 diabetes on potent P2Y<sub>12</sub> inhibitorsBenjamin Panzer, Patricia P Wadowski, Kurt Huber, et al.
International Journal of Cardiology|April 10, 2012
Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular eventsChristoph H Saely, Philipp Rein, Alexander Vonbank, et al.
European Heart Journal. Acute Cardiovascular Care|May 26, 2026
Proteomics profiling for cardiovascular risk prediction: transforming clinical careIsabella Kardys, Manuel Mayr, Johannes Mair, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 17, 2015
Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly menTijana Andric, Thomas W Weiss, Kurt Huber, et al.
Intensive Care Medicine|June 27, 2003
Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shockAlexander Geppert, Angela Steiner, Georg Delle-Karth, et al.
International Journal of Clinical Pharmacy|November 8, 2022
Pharmacist interventions to improve blood pressure control in primary care: a cluster randomised trialMiklos Rohla, Heinz Haberfeld, Maximilian Tscharre, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 15, 2010
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 updateThomas Cuisset, Marco Valgimigli, Harald Mudra, et al.
Pageof 76